Tetrazepam

What is Tetrazepam?

Tetrazepam is a benzodiazepine derivative once primarily used for its muscle relaxant and anxiolytic properties. It acted on the central nervous system (CNS) to calm, reduce muscle tone, and alleviate anxiety. Popular in some European countries for muscle spasticity and discomfort, it was withdrawn from most markets, including the EU, due to safety concerns. These included risks of severe skin reactions, dependence, and abuse. Its main indication was painful muscle contractures and muscle spasms often with anxiety.

How Does it Work?

Like other benzodiazepines, Tetrazepam enhanced gamma-aminobutyric acid (GABA) activity, the brain's main inhibitory neurotransmitter. It bound to specific sites on the GABA-A receptors complex, increasing chloride ion influx into neurons. This hyperpolarized neurons, making them less excitable and depressing CNS activity. This led to:

• Anxiolytic effects: Reducing neuronal excitability in fear-related brain areas.
• Muscle relaxant effects: Acting on spinal cord interneurons to reduce hypertonia and spasticity.
• Sedative effects: Generally slowing brain activity, causing drowsiness.

Its pronounced muscle relaxant properties made it particularly useful for musculoskeletal conditions.

Medical Uses

Historically, Tetrazepam treated painful muscle contractures and muscle spasms in conditions like:

• Acute low back pain with muscle spasms.
• Cervicalgia (neck pain) from muscle tension.
• Musculoskeletal pain with significant muscle spasticity.

It also eased anxiety linked to these physical conditions. Use was short-term due to tolerance and dependence risks, common with benzodiazepines. Withdrawal stemmed from reports of serious skin reactions (e.g., Stevens-Johnson syndrome, toxic epidermal necrolysis) and the availability of safer alternatives.

Dosage

The dosage of Tetrazepam varied by patient and symptom. Typical adult dosages for muscle spasms and anxiety were generally:

• Starting dose: Often 25 mg to 50 mg per day.
• Maintenance dose: Typically 50 mg to 100 mg per day, divided into one or two doses.

Maximum dose was usually 150 mg per day. It was vital to start with the lowest effective dose, increase gradually under strict medical supervision, and use for short periods, usually not exceeding a few weeks. Abrupt discontinuation was avoided, with a gradual tapering schedule recommended to minimize withdrawal effects. Elderly patients or those with hepatic or renal impairment needed dose adjustments.

Side Effects

Like all medications, Tetrazepam could cause various side effects, some common and others more serious.

Common Side Effects:

• Drowsiness, dizziness, fatigue
• Muscle weakness, ataxia (impaired coordination)
• Dry mouth, headache

Serious Side Effects (contributed to its withdrawal):

• Severe Skin Reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema multiforme (rare but potentially life-threatening).
• Dependence and Withdrawal: Prolonged use could lead to physical and psychological dependence. Abrupt cessation could trigger severe withdrawal symptoms, including seizures, tremors, insomnia, and severe anxiety.
• Paradoxical Reactions: In some individuals, benzodiazepines could cause agitation, hallucinations, or aggression.
• Respiratory Depression: Especially at higher doses or when combined with other CNS depressants.

These significant risks, particularly the severe skin reactions and the well-known risks of benzodiazepine dependence, led to its market withdrawal.

Drug Interactions

Tetrazepam, being a benzodiazepine and a CNS depressant, could interact with various other medications and substances, potentially increasing the risk of adverse effects. Key drug interactions included:

• Other CNS Depressants: Concurrent use with alcohol, opioids, other benzodiazepines, tricyclic antidepressants, antihistamines, antipsychotics, or general anesthetics could significantly enhance sedative effects, leading to profound drowsiness, respiratory depression, or coma.
• Muscle Relaxants: Combining Tetrazepam with other muscle relaxants could exacerbate muscle weakness and sedation.
• Cytochrome P450 Inhibitors: Drugs that inhibit certain liver enzymes (e.g., CYP3A4 inhibitors like erythromycin, ketoconazole, cimetidine) could reduce the metabolism of Tetrazepam, leading to increased blood levels and a higher risk of side effects.

Patients were always advised to inform their healthcare provider about all medications, supplements, and herbal products they were taking to prevent potentially dangerous interactions.

Frequently Asked Questions About Tetrazepam

Is Tetrazepam still available for use?

No, Tetrazepam has been withdrawn from the market in many countries, including across the European Union, due to concerns over its safety profile. It is generally no longer prescribed.

What was Tetrazepam primarily used for?

It was primarily used as a muscle relaxant for treating painful muscle contractures and muscle spasms, also addressing associated anxiety.

Is Tetrazepam addictive?

Yes, like other benzodiazepines, Tetrazepam carried a significant risk of physical and psychological dependence, especially with prolonged use.

What are the alternatives to Tetrazepam for muscle spasms?

Many alternatives exist for treating muscle spasms and anxiety, including other muscle relaxants (e.g., baclofen, tizanidine, cyclobenzaprine), non-benzodiazepine anxiolytics, physical therapy, and pain management strategies. A healthcare professional can recommend the most appropriate treatment.

Why was Tetrazepam withdrawn from the market?

The withdrawal was primarily due to reports of rare but serious and potentially fatal skin reactions (e.g., Stevens-Johnson syndrome, toxic epidermal necrolysis), combined with its well-known potential for dependence and abuse, and the availability of safer alternative treatments.

Products containing Tetrazepam are available through trusted online pharmacies. You can browse Tetrazepam-based medications at ShipperVIP or Medicenter.

Summary

Tetrazepam was a benzodiazepine derivative known for its muscle relaxant and anxiolytic properties, historically prescribed for painful muscle contractures and muscle spasms accompanied by anxiety. Its mechanism of action involved enhancing GABAergic inhibition in the CNS, leading to reduced neuronal excitability. While effective for its indicated uses, its market presence was ultimately curtailed due to significant safety concerns, most notably the risk of severe skin reactions and the well-documented potential for dependence and withdrawal associated with benzodiazepines. Consequently, Tetrazepam is no longer widely available or prescribed. Patients experiencing muscle spasms or anxiety should consult a healthcare professional to explore current, safer therapeutic options. Understanding the history of drugs like Tetrazepam underscores the ongoing commitment to patient safety and the evolution of pharmaceutical guidelines.